Immutep (IMMP) Convertible Debt (2016 - 2025)
Immutep (IMMP) Convertible Debt (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.50 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn |
| 4 | Moderna | 58.98 Bn | 53.84 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - |
| 10 | Immutep | 56.27 Mn | -8.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 707,600.56 |
| Dec 31, 2024 | 675,283.43 |
| Jun 30, 2024 | 633,166.34 |
| Dec 31, 2023 | 584,539.33 |
| Jun 30, 2023 | 558,379.06 |
| Dec 31, 2022 | 513,004.59 |
| Jun 30, 2022 | 1.04 Mn |
| Dec 31, 2021 | 1.98 Mn |
| Jun 30, 2021 | 1.95 Mn |
| Dec 31, 2020 | 6.90 Mn |
| Jun 30, 2020 | 5.76 Mn |
| Dec 31, 2019 | 5.61 Mn |
| Jun 30, 2019 | 5.35 Mn |
| Dec 31, 2018 | 5.12 Mn |
| Jun 30, 2018 | 5.03 Mn |
| Jun 30, 2017 | 4.34 Mn |
| Mar 31, 2017 | 4.23 Mn |
| Jun 30, 2016 | 3.75 Mn |